RT Journal Article
SR Electronic
T1 Empiric model for short-time prediction of COVID-19 spreading
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.13.20101329
DO 10.1101/2020.05.13.20101329
A1 Martí Català
A1 Sergio Alonso
A1 Enrique Alvarez-Lacalle
A1 Daniel López
A1 Pere-Joan Cardona
A1 Clara Prats
YR 2020
UL http://medrxiv.org/content/early/2020/05/19/2020.05.13.20101329.abstract
AB Covid-19 appearance and fast spreading took by surprise the international community. Collaboration between researchers, public health workers and politicians has been established to deal with the epidemic. One important contribution from researchers in epidemiology is the analysis of trends so that both current state and short-term future trends can be carefully evaluated. Gompertz model has shown to correctly describe the dynamics of cumulative confirmed cases, since it is characterized by a decrease in growth rate that is able to show the effect of control measures. Thus, it provides a way to systematically quantify the Covid-19 spreading velocity. Moreover, it allows to carry out short-term predictions and long-term estimations that may facilitate policy decisions and the revision of in-place confinement measures and the development of new protocols. This model has been employed to fit the cumulative cases of Covid-19 from several Chinese provinces and from other countries with a successful containment of the disease. Results show that there are systematic differences in spreading velocity between countries. In countries that are in the initial stages of the Covid-19 outbreak, model predictions provide a reliable picture of its short-term evolution and may permit to unveil some characteristics of the long-term evolution. These predictions can also be generalized to short-term hospital and Intensive Care Units (ICU) requirements, which together with the equivalent predictions on mortality provide key information for health officials.Author summary Covid-19 has brought international scientific community into the eye of a storm. Collaboration between researchers, public health workers and politicians is essential to deal with this challenge. One of the pieces of the puzzle is the analysis of May 7, epidemiological trends so that both current and immediate future situation can be carefully evaluated. For this reason we have daily employed a generic growing function to describe the cumulative cases of Covid-19 in several countries and regions around the world and particularly for European countries during the Covid-19 outbreak in Europe. Our model is completely empiric and it is not using any assumption to make the predictions, only the daily update of new cases. In this manuscript, we detail the methods employed and the degree of confidence we have obtained during this process. This can be used for other researchers collaborating and advising health institutions around the world for the Covid-19 outbreak or any other epidemic that follows the same pattern.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCP, PJC and MC received funding from La Caixa Foundation (ID 100010434), under agreement LCF/PR/GN17/50300003; PJC received funding from Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR), Grup Unitat de Tuberculosi Experimental, 2017-SGR-500; P, DL, SA, MC received funding from Ministerio de Ciencia, Innovación y Universidades and FEDER, with the project PGC2018-095456-B-I00. This work has been also partially funded by the European Comission - DG Communications Networks, Content and Technology through the contract LC-01485746.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019/situation-reports